The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February

The Oncology Institute, Inc. (NASDAQ:TOI) was the target of a large increase in short interest in February. As of February 15th, there was short interest totalling 934,800 shares, an increase of 188.3% from the January 31st total of 324,300 shares. Approximately 2.5% of the company’s stock are sold short. Based on an average daily volume of 1,970,000 shares, the days-to-cover ratio is presently 0.5 days.

Oncology Institute Price Performance

NASDAQ TOI opened at $0.89 on Friday. The firm’s 50 day moving average price is $0.63 and its 200-day moving average price is $0.41. Oncology Institute has a 52-week low of $0.13 and a 52-week high of $2.10. The company has a debt-to-equity ratio of 5.91, a quick ratio of 2.27 and a current ratio of 2.49. The company has a market cap of $67.26 million, a PE ratio of -1.14 and a beta of 0.37.

Institutional Trading of Oncology Institute

A number of institutional investors have recently modified their holdings of TOI. FreeGulliver LLC increased its holdings in shares of Oncology Institute by 219.3% in the fourth quarter. FreeGulliver LLC now owns 600,747 shares of the company’s stock valued at $186,000 after purchasing an additional 412,578 shares during the period. Tiff Advisory Services LLC raised its position in shares of Oncology Institute by 13.2% during the 4th quarter. Tiff Advisory Services LLC now owns 2,979,141 shares of the company’s stock worth $921,000 after purchasing an additional 346,256 shares during the last quarter. Virtu Financial LLC purchased a new stake in shares of Oncology Institute during the fourth quarter worth approximately $41,000. Jane Street Group LLC lifted its stake in shares of Oncology Institute by 613.6% in the fourth quarter. Jane Street Group LLC now owns 127,659 shares of the company’s stock worth $39,000 after buying an additional 109,769 shares in the last quarter. Finally, HighTower Advisors LLC lifted its position in Oncology Institute by 190.8% during the third quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock worth $27,000 after buying an additional 53,382 shares in the last quarter. 36.86% of the stock is currently owned by institutional investors.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.